Expected cost savings from climate change mitigation actions

Unit

i
: Currency

Indicator

i
: Business exposure to nature risks and opportunities

Metric type

i
: Other

Framework alignment notes

i
ESRS E1-9 69a
GBF Target 8, Target 15

Target example
i

[Company name] aims to achieve operational cost savings of [target amount, in local currency] by [target year]

Target source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Raw Materials Manufacturing End of Life

Metric assessment

i
Relevance: High
i
Feasibility: Low
i

Related actions

i

Reduce GHG emissions from operations and land use activities

Reduce GHG emissions from operations and land use activities

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce GHG emissions in products

Reduce GHG emissions in products

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Develop and implement sourcing guidelines that prioritize sustainable commodities and suppliers committed to sustainable practices

Develop and implement sourcing guidelines that prioritize sustainable commodities and suppliers committed to sustainable practices

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Focus on deforestation-and conversion-free (DCF) production, in line with biome-specific guidelines and cutoff dates.

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon